Eur Respir J:慢性咳嗽和慢性疼痛之间的相互关系

2020-11-01 MedSci原创 MedSci原创

慢性咳嗽和慢性疼痛之间可相互提高各自风险,表明这两种疾病可能具有共同的危险因素和/或病理生理机制。

由于慢性咳嗽与慢性疼痛具有共同的神经生物学机制和病理生理学机制,因此,这两种临床疾病可能相互关联。近日,呼吸疾病领域权威杂志Eur Respir J上发表了一篇研究文章,研究人员通过一项基于前瞻性人群的大型队列研究评估了成人咳嗽与慢性疼痛之间的关系。

研究人员采用标准化问卷,将慢性疼痛定义为持续6个月以上的疼痛,并根据疼痛频率分为每周/每月或每天疼痛。慢性咳嗽被描述为每天咳嗽至少3个月。研究人员采用纵向和横截面关联进行双向分析。

在7141名受试者中,54%(n=3888)的受试者在基线时报告有慢性疼痛。每日慢性疼痛和慢性咳嗽的共患病率为4.4%。与没有慢性疼痛的患者相比,每天和每周/每月的慢性疼痛患者的慢性咳嗽发生率更高(分别为13.8%和10.3% vs. 8.2%,p<0.001)。在调整了潜在的混杂因素后,慢性疼痛患病率与慢性咳嗽显著相关(OR为1.47,95%CI为1.08-1.99)。在每日慢性疼痛的受试者(OR为1.49,95%CI为1.06-2.11)中,该关联仍然显著,尽管与每周/每月慢性疼痛的受试者(OR为1.43,95%CI为0.98-2.10)相似,但估计值无显著差异。在调整了协变量之后,与没有慢性咳嗽的受试者相比,慢性咳嗽受试者发生慢性疼痛的风险显著增加(OR为1.63,95%CI为1.02-2.62)。

由此可见,慢性咳嗽和慢性疼痛之间可相互提高各自风险,表明这两种疾病可能具有共同的危险因素和/或病理生理机制。

原始出处:

Johnmary T. Arinze,et al.The interrelatedness of chronic cough and chronic pain.Eur Respir J.2020.https://erj.ersjournals.com/content/early/2020/10/22/13993003.02651-2020

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1684031, encodeId=6d57168403102, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Wed Nov 25 19:03:47 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260065, encodeId=f0f4126006505, content=<a href='/topic/show?id=fd52535e38b' target=_blank style='color:#2F92EE;'>#慢性疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53573, encryptionId=fd52535e38b, topicName=慢性疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=976a57, createdName=liubm555, createdTime=Tue Nov 03 13:03:47 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896202, encodeId=738d896202f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60b22056515, createdName=1381ecf10dm, createdTime=Mon Nov 02 10:42:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896127, encodeId=6c3789612e6c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47215430920, createdName=ms2000000321088013, createdTime=Sun Nov 01 22:53:01 CST 2020, time=2020-11-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1684031, encodeId=6d57168403102, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Wed Nov 25 19:03:47 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260065, encodeId=f0f4126006505, content=<a href='/topic/show?id=fd52535e38b' target=_blank style='color:#2F92EE;'>#慢性疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53573, encryptionId=fd52535e38b, topicName=慢性疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=976a57, createdName=liubm555, createdTime=Tue Nov 03 13:03:47 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896202, encodeId=738d896202f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60b22056515, createdName=1381ecf10dm, createdTime=Mon Nov 02 10:42:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896127, encodeId=6c3789612e6c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47215430920, createdName=ms2000000321088013, createdTime=Sun Nov 01 22:53:01 CST 2020, time=2020-11-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1684031, encodeId=6d57168403102, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Wed Nov 25 19:03:47 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260065, encodeId=f0f4126006505, content=<a href='/topic/show?id=fd52535e38b' target=_blank style='color:#2F92EE;'>#慢性疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53573, encryptionId=fd52535e38b, topicName=慢性疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=976a57, createdName=liubm555, createdTime=Tue Nov 03 13:03:47 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896202, encodeId=738d896202f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60b22056515, createdName=1381ecf10dm, createdTime=Mon Nov 02 10:42:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896127, encodeId=6c3789612e6c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47215430920, createdName=ms2000000321088013, createdTime=Sun Nov 01 22:53:01 CST 2020, time=2020-11-01, status=1, ipAttribution=)]
    2020-11-02 1381ecf10dm

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1684031, encodeId=6d57168403102, content=<a href='/topic/show?id=36d3e251666' target=_blank style='color:#2F92EE;'>#相互关系#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72516, encryptionId=36d3e251666, topicName=相互关系)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34fc28021308, createdName=fengting12, createdTime=Wed Nov 25 19:03:47 CST 2020, time=2020-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1260065, encodeId=f0f4126006505, content=<a href='/topic/show?id=fd52535e38b' target=_blank style='color:#2F92EE;'>#慢性疼痛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53573, encryptionId=fd52535e38b, topicName=慢性疼痛)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=976a57, createdName=liubm555, createdTime=Tue Nov 03 13:03:47 CST 2020, time=2020-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896202, encodeId=738d896202f3, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60b22056515, createdName=1381ecf10dm, createdTime=Mon Nov 02 10:42:41 CST 2020, time=2020-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=896127, encodeId=6c3789612e6c, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47215430920, createdName=ms2000000321088013, createdTime=Sun Nov 01 22:53:01 CST 2020, time=2020-11-01, status=1, ipAttribution=)]
    2020-11-01 ms2000000321088013

    学习了

    0

相关资讯

Postgrad Med:大麻二酚可替代阿片类药物改善慢性疼痛患者的疼痛及生活质量

慢性疼痛普遍存在,尽管阿片类药物治疗慢性疼痛的副作用较多,但是其广泛用于慢性疼痛的治疗。大麻素,特别是大麻二酚,被提出作为阿片类药物的替代品,具有类似的疗效和更好的安全性。本研究旨在探究全麻提取物大麻

IJIR:阴茎勃起功能异常能够影响慢性疼痛男性的人格和精神障碍

慢性疼痛患者中的人格障碍(PDs)和性功能异常患病率要比普通人群高。最近,有研究人员分析了阴茎勃起功能障碍和具有慢性非癌疼痛患者中的PD影响,以及他们对雄激素治疗的响应情况。

慢性疼痛与免疫系统密不可分

疼痛有三种主要类型:一是伤害性疼痛;二是神经性疼痛;三是功能性疼痛。

Crit Care Med:危重病后慢性疼痛的发生和危险因素

由此可见,新发慢性疼痛是重症患者的常见结局,其对患者的日常生活影响巨大。

J Neurosci:美研究发现一种与慢性疼痛有关的蛋白

慢性疼痛不仅让人长期感觉疼痛,还会导致感觉迟钝甚至抑郁。现有一些镇痛药虽可缓解慢性疼痛,但可能会带来上瘾等严重副作用。美国一项新研究发现,一种名为RGS4的蛋白与慢性疼痛相关,未来有助于开发新的治疗疼痛药物。

BMC Musculoskelet Disord:颅骶疗法可有效治疗慢性疼痛

本研究旨在系统评估颅骶疗法(CST)治疗慢性疼痛的证据,研究结果已在线发表于。